Literature DB >> 12905555

Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy.

M Simunovic1, R Sexton, E Rempel, B J Moran, R J Heald.   

Abstract

BACKGROUND: Radiation is being used increasingly in the management of patients with rectal cancer. Over the past decade the Basingstoke Colorectal Research Unit has combined precision total mesorectal excision with the highly selective use of preoperative radiotherapy.
METHODS: One hundred and fifty consecutive patients who underwent major surgical excision for cancers of all stages comprised the study group. Preoperative clinical assessment was based largely on tumour size, fixation and distance from the anal verge. Only preoperative radiotherapy was considered and this only for tumours judged to be at high risk of mesorectal fascia involvement.
RESULTS: During a 5-year period 35 of 150 patients were selected for preoperative irradiation. In the non-irradiated patients the local recurrence rate after a median follow-up period of 870 (range 51-1903) days was 2.6 per cent (three of 115 patients), compared with 17.1 per cent (six of 35 patients) in those chosen for irradiation. Sixty patients (52.2 per cent) who were not irradiated were node positive. The local recurrence rate for the whole group was 6.0 per cent.
CONCLUSION: The great majority of patients undergoing major excision for rectal cancer can be managed without radiation therapy if the preoperative assessment of the mesorectal fascia and surgery are performed optimally. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12905555     DOI: 10.1002/bjs.4210

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

1.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Fábio G Campos; Wladimir Nadalin; Desiderio Kiss; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

2.  Impact of anatomic location on locally recurrent rectal cancer: superior outcome for intraluminal tumour recurrence.

Authors:  Johannes Klose; Ignazio Tarantino; Thomas Schmidt; Thomas Bruckner; Yakup Kulu; Tobias Wagner; Martin Schneider; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2015-03-31       Impact factor: 3.452

3.  [Even guidelines must be allowed to be questioned].

Authors:  Y Kulu; T Hackert; J Debus; M-A Weber; M W Büchler; A Ulrich
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

4.  Laparoscopic-assisted approach in rectal cancer patients: lessons learned from >200 patients.

Authors:  S Delgado; D Momblán; L Salvador; R Bravo; A Castells; A Ibarzabal; J M Piqué; A M Lacy
Journal:  Surg Endosc       Date:  2004-08-26       Impact factor: 4.584

5.  Practicability of quality goals for the treatment of rectal cancer.

Authors:  Sigmar Stelzner; Gunter Hellmich; Gunter Haroske; Erik Puffer; Thomas Jackisch; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2010-06-12       Impact factor: 2.571

6.  Selective use of preoperative chemoradiotherapy for T3 rectal cancer can be justified: analysis of local recurrence.

Authors:  Se-Jin Baek; Seon-Hahn Kim; Jung-Myun Kwak; Jae-Sung Cho; Jae-Won Shin; Azali Hafiz Yafee Amar; Jin Kim
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

7.  Relationship between diversion colitis and quality of life in rectal cancer.

Authors:  Dong Nyoung Son; Dong Jin Choi; Si Uk Woo; Jin Kim; Bo Ra Keom; Chul Hwan Kim; Se Jin Baek; Seon Hahn Kim
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

8.  Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Jorge Sabbaga; Ulysses Ribeiro; Afonso Henrique Silva e Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

Review 9.  Multidisciplinary treatment of rectal cancer in 2014: where are we going?

Authors:  Andrea Vignali; Paola De Nardi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 10.  Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know.

Authors:  Rolv-Ole Lindsetmo; Yong-Geul Joh; Conor-P Delaney
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.